LENSAR, Inc.

NASDAQ:LNSR

Medical - Devices

Healthcare
$4.64 -8.15%

-$0.51 today

Market cap
$57.05M
Beta
0.87
P/E (TTM)
2.4
EPS (TTM)
$2.42
52W Low $5.06High $13.47

Volume 0.04M

Average 0.09M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$14.83M

FY 2025 · Annual

Investing Cash Flow

$1.28M

FY 2025 · Annual

Financing Cash Flow

$10.26M

FY 2025 · Annual

+13051.3% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(19.6M)(19.91M)(14.38M)(31.4M)(34.28M)
Depreciation & Amortization2.76M3.41M3.52M3.93M4.5M
Deferred Income Tax527K0000
Stock-Based Compensation6.87M6.61M5.54M2.67M3.14M
Change in Working Capital(42K)(5.58M)(7.78M)(3.04M)1.1M
Accounts Receivables(2.65M)(1.44M)1.08M(2.1M)289K
Inventory2.33M(6.89M)(7.46M)(4.9M)(13.9M)
Accounts Payables213K2.73M(1.42M)1.96M12.99M
Other Working Capital66K23K23K2M1.72M
Other Non-Cash Items517K618K3.45M25.58M10.7M
Operating Cash Flow(8.97M)(14.86M)(9.66M)(2.28M)(14.83M)
Capital Expenditures(354K)(115K)(236K)(156K)(83K)
Acquisitions (Net)00000
Purchases of Investments00(3.92M)(10.25M)(11.88M)
Sales of Investments0008.24M13.25M
Other Investing Activities00000
Investing Cash Flow(354K)(115K)(4.16M)(2.16M)1.28M
Debt Repayment00000
Common Stock Issued361K408K058K258K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(2.4M)5.88M20K10M
Financing Cash Flow361K(1.99M)19.76M78K10.26M
Effect of Forex Changes00000
Net Change in Cash(8.96M)(16.96M)5.95M(4.36M)(3.29M)
Free Cash Flow(9.32M)(14.97M)(9.9M)(2.43M)(14.91M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$34.3M
+ D&A$4.5M
+ Stock-Based Comp$3.1M
+ Deferred Tax$0
+ Working Capital$1.1M
+ Other Non-Cash$10.7M
= Operating Cash Flow-$14.8M
- Capex-$83.0K
= Free Cash Flow-$14.9M

Analysis

FY2025 free cash flow is -$14.9M. FCF conversion is 43.5% of net income. Operating cash flow was -$14.8M, with capex of -$83.0K. The largest bridge item is Other Non-Cash at $10.7M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
10-QQuarterly reportAug 13, 2026
8-KCurrent reportAug 13, 2026

Does LNSR generate free cash flow?

LENSAR, Inc. (LNSR) generated -$14.91M of free cash flow in fiscal 2025.

How much operating cash flow does LNSR produce?

Operating cash flow was -$14.83M, before capital expenditures of $83,000.00.